KEGG pathway enrichment results demonstrated that core target genes were enriched in signaling pathways including PI3K/Akt, Proteoglycans in cancer, AGE/RAGE, and EGFR, suggesting that CS could exert its anti-RIF effect by targeting these biological processes and signaling pathways. The gene discussed is EGFR; the disease is cancer.